Literature DB >> 33687549

Re-sleeping after reversal of remimazolam by flumazenil.

Tomohiro Yamamoto1, Miyuki Kurabe2, Yoshinori Kamiya2.   

Abstract

Entities:  

Keywords:  Flumazenil; Re-sleeping; Remimazolam; Reversal

Mesh:

Substances:

Year:  2021        PMID: 33687549     DOI: 10.1007/s00540-021-02915-x

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  10 in total

1.  Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study.

Authors:  Takehito Sato; Kimitoshi Nishiwaki
Journal:  J Anesth       Date:  2021-11-15       Impact factor: 2.078

2.  Long-term delayed emergence after remimazolam-based general anesthesia: a case report.

Authors:  Tsubasa Takemori; Yoshimasa Oyama; Takenori Makino; Seigo Hidaka; Takaaki Kitano
Journal:  JA Clin Rep       Date:  2022-10-19

3.  Review of remimazolam and sedatives in the intensive care unit.

Authors:  Hey-Ran Choi; In-Ae Song
Journal:  Acute Crit Care       Date:  2022-05-30

4.  Factors affecting prolonged time to extubation in patients given remimazolam.

Authors:  Yoko Shimamoto; Michiyoshi Sanuki; Shigeaki Kurita; Masaya Ueki; Yoshie Kuwahara; Ayumu Matsumoto
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.240

Review 5.  Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.

Authors:  Yasuhiro Morimoto
Journal:  Ther Clin Risk Manag       Date:  2022-02-02       Impact factor: 2.423

Review 6.  Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.

Authors:  Kyung Mi Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2022-01-20

7.  Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study.

Authors:  Insun Park; Mincheul Cho; Sun Woo Nam; Jung-Won Hwang; Sang-Hwan Do; Hyo-Seok Na
Journal:  BMC Anesthesiol       Date:  2022-07-26       Impact factor: 2.376

8.  Remimazolam and low-dose flumazenil for awake craniotomy.

Authors:  Hiroaki Murata; Akihiro Yokoyama; Tetsuya Hara
Journal:  J Anesth       Date:  2022-09-12       Impact factor: 2.931

9.  General anesthesia with remimazolam for a pediatric patient with MELAS and recurrent epilepsy: a case report.

Authors:  Yusuke Yamadori; Yuki Yamagami; Yukihisa Matsumoto; Mari Koizumi; Akiyo Nakamura; Daiskuke Mizuta; Kyoko Yasuda; Gotaro Shirakami
Journal:  JA Clin Rep       Date:  2022-09-16

Review 10.  Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress.

Authors:  Mi Wang; Xian Zhao; Pengfei Yin; Xiuxia Bao; Hongli Tang; Xianhui Kang
Journal:  Drug Des Devel Ther       Date:  2022-10-03       Impact factor: 4.319

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.